搜索公司,投资者……

Rubicor医疗

rubicor.com

成立一年

1998年

阶段

C系列 |活着

总了

30美元

最后提出了

30美元 | 17年前

关于Rubicor医疗

Rubicor医疗是一个私人医疗设备公司位于红木市,加利福尼亚。我们的专有活检技术(鼓掌乳房活检设备)是一个戏剧性的改善当前微创活检技术。14号的Ovation系统由活检设备切割的能力,捕捉和提取完整的2.5厘米直径的组织样本。热烈欢迎兼容超声波或立体定向形象指导。Rubicor由詹姆斯检查者和博士已经与私人资助的个人投资者组成的财团。詹姆斯·w .检查者,医学博士首席执行官和董事会主席,是一个委员会认证的介入心脏病学家。他是斯坦福大学医院临床医学副教授,他在那里目前活跃的员工作为社区学院。检查者博士毕业于威斯康辛医学院,他完成了一个居住在内科和心脏病的奖学金。检查者博士完成了介入性心脏病学和约翰·辛普森博士,医学博士奖学金。在红杉医院,加州雷德伍德城。 Dr. Vetter is a member of the Alpha Omega Alpha Honor Society and the American College of Cardiologists. He has published six articles and several book chapters as well as over 35 abstracts. Dr. Vetter has held positions as a member of the Physician Advisory Council and/or board member with a number of medical device companies including Guidant, Lumend, Fox Hollow and CardioVasc. He is also a board member of Magellan Systems International, Inc. Dr. Vetter has extensive experience in working with new medical device concepts and designs, working with R&D engineers to develop working prototypes and clinically testing and refining those products. He was co-founder of Perclose and was involved with that company from inception to initial public offering and eventual sale to Abbott Labs. He is a "hands on" clinician with access to resources and expertise needed to build a successful medical device and company. Dr. Vetter has had a number of patents issued in his name as co-inventor. Ary Chernomorsky, V.P. of R&D since 2000 has over 23 years experience in the medical device industry. Prior to joining Rubicor, Mr. Chernomorsky was employed by the Vascular Therapies division of US Surgical Company (acquired by Tyco International), where he served as a Director of R&D. Mr. Chernomorsky has been involved with various startup companies in the R&D Director and Manager capacities including: PAS Inc. (acquired by USS), Advanced Surgical, Inc. (acquired by Imagyn), Micro Therapeutics, Bausch and Lomb, Mentor Corporation and Dart Industries Inc. Ary holds an M.S. in Polymer Engineering from LIT and an M.S. in Biomedical Engineering from Rutgers University. Tony Difede, CPA, V.P. Finance holds a BSBA degree in Accounting from the University of Florida and a M.S. in Taxation from Pace University. He has held management positions in tax and accounting with Ernst & Young, KPMG and my CFO, Inc. His clients have included closely held start-up companies as well as large multinational public corporations. He is licensed in California and New Jersey. He has extensive experience in accounting for stock options and issues regarding closely held companies and their high net worth owners and investors. COMPANY INFO MANAGEMENT page 1 2006 Company Overview (Continued) Breast care. Completely redefined. James W. Vetter, M.D., Founder and Chairman of the Board, is a board certified interventional cardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of the Medical College of Wisconsin where he completed a residency in internal medicine and a fellowship in cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John Simpson M.D./PhD., at Sequoia Hospital, Redwood City, Cal

总部的位置

600切萨皮克驱动器

红木市,加州,94063年,

美国

650-587-3447

缺失:Rubicor医疗产品演示和案例研究

促进你的产品提供技术买家。

达到1000年代的买家使用CB的见解来确定供应商,演示产品,德赢体育vwin官方网站做出购买决定。

缺失:Rubicor医疗产品&微分器

不要让你的产品被跳过。买家使用我们的供应商排名名单公司和驱动(rfp)请求建议。

集合包含Rubicor医疗专家

专家集合是analyst-curated列表,突出了公司你需要知道的最重要的技术空间。

Rubicor医疗中1专家收集,包括生物制药技术

B

生物制药技术

5241件

公司参与研究、开发和商业化的化学或生物衍生& theranostic治疗药物。不包括维生素/补充剂,横/临床试验服务。

Rubicor医疗专利

Rubicor医疗提起了12项专利。

专利图

申请日

授予日期

标题

相关的话题

状态

12/30/2009

5/1/2012

投资基金、旋转、真皮和皮下生长

格兰特

申请日

12/30/2009

授予日期

5/1/2012

标题

相关的话题

投资基金、旋转、真皮和皮下生长

状态

格兰特

Rubicor医疗常见问题(FAQ)

  • Rubicor医疗是何时成立的?

    Rubicor医疗成立于1998年。

  • Rubicor医疗的总部在哪里?

    Rubicor医疗的总部位于600切萨皮克驱动器,雷德伍德城。

  • Rubicor医学的最新一轮融资是什么?

    Rubicor医学的最新一轮融资系列C。

  • Rubicor医疗筹集了多少钱?

    Rubicor医学提出了总共30美元。

  • Rubicor医疗的投资者是谁?

    投资者Rubicor医学包括维护科学和财年国际。

  • Rubicor医疗的竞争对手是谁?

    Rubicor医疗的竞争对手包括JJET连杆生物科学,Aviir VitaPath遗传学、波节性和9。

比较Rubicor医疗竞争对手

J
JJET

JJET致力于开发、生产和销售的产品领域的电生理学;产品主要包括三维心脏映射系统,多道生理记录仪,心脏电生理刺激,心脏射频消融设备,冷盐水灌注泵、心脏电生理导管的映射,心脏射频消融导管,神经射频治疗仪器。公司成立于1991年,总部设在成都,中国。

F
Flex生物医学

Flex生物医学发展技术能帮助我们找到诊断和治疗骨科疾病。Flex生物医学的主要产品是合成聚合物,Flex聚合物,用于治疗骨关节炎。

l
Litholink

Litholink提供代谢评估肾脏结石患者。

T
热能

TECO提供加热和冷却区服务在德州医学中心校园建筑在休斯顿,德克萨斯州。该公司运营两个加热和冷却植物总容量80000吨的冷冻水和蒸汽生产的762000磅/小时。

X
Xeptagen公司。

XEPTAGEN水疗中心从事分子标志物的发现和验证以产生早期检测诊断包,监视和检查癌细胞。利用天然免疫反应早期癌症和组合蛋白质组学平台技术,XEPTAGEN发现了特定的肿瘤标记,导致更早和更准确检测患癌。公司的任务包括创建工具,提高诊断准确性对癌症和癌症患者的临床管理。

IMMUTELL

Immutell致力于开发、生产和市场细胞介导免疫反应诊断帮助对抗疾病很难诊断。

发现正确的解决方案为您的团队

CB见解德赢体育vwin官方网站科技市场情报平台分析数百万数据点在供应商、产品、合作关系,专利来帮助您的团队发现他们的下一个技术解决方案。

请求一个演示

CBI的网站通常使用一些饼干,使更好的相互作用我们的网站和服务。使用这些饼干,这可能是存储在你的设备上,允许我们的改进和定制你的经历。你可以阅读更多关于你的饼干的选择在我们的隐私政策在这里。继续使用这个你同意这些选择。

Baidu
map